Inventor · disambiguated record
Yingjie Lai
Also filed as: LAI YINGJIE
14 granted patents·7 pending applications·127 citations·filing 2000–2019
91Inventor score
Files withMERCK & CO INC3CHEN LI2CHEN STONE GUANGZHOU CO LTD2GENENTECH INC2GUANGDONG MOLTECH PHARMA CO LTD2
Top patents by PatentIndex Score
21 records- 0190US6458790B2Substituted piperidines as melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Oct 1, 2002·56 cites·29 claims
- 0288US8486950B2Janus kinase inhibitor compounds and methodsGOODACRE SIMON CHARLES·Filed 2010·Granted Jul 16, 2013·25 cites·19 claims
- 0386US8318719B2Inhibitors of Bruton's tyrosine kinaseDEWDNEY NOLAN JAMES·Filed 2010·Granted Nov 27, 2012·12 cites·37 claims
- 0481US9309240B2Pyrazolopyridine compounds, compositions and methods of useHOFFMANN LA ROCHE·Filed 2013·Granted Apr 12, 2016·6 cites·16 claims
- 0580US8119644B2Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2009·Granted Feb 21, 2012·3 cites·37 claims
- 0677US6972287B1Method of inhibiting amyloid protein aggregation and imaging amyloid depositsPFIZER·Filed 2000·Granted Dec 6, 2005·10 cites·28 claims
- 0775US6767915B2Substituted piperidines as melanocortin receptor agonistsMERCK & CO INC·Filed 2001·Granted Jul 27, 2004·9 cites·29 claims
- 0874US8697708B2Azabenzothiazole compounds, compositions and methods of useBLENCH TOBY JONATHAN·Filed 2011·Granted Apr 15, 2014·3 cites·1 claims
- 0970US9173861B2Thiadiazole-substituted arylamides as P2X3 and P2X2/3 antagonistsCHEN LI·Filed 2012·Granted Nov 3, 2015·1 cites·20 claims
- 1064US7329673B2Acylated spiropiperidine derivatives as melanocortin-4 receptor agonistsMERCK & CO INC·Filed 2004·Granted Feb 12, 2008·2 cites·22 claims
- 1157US10487058B2Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereofGUANGDONG MOLTECH PHARMA CO LTD·Filed 2019·Granted Nov 26, 2019·0 cites·5 claims
- 1252US2014171408A1Azabenzothiazole compounds, compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 1350US2010144758A1Azaindole p2x3 and p2x2/3 modulatorsDILLON MICHAEL PATRICK·Filed 2009·Application pending·0 cites
- 1448US2017081320A1Thiadiazole-substituted arylamides as p2x3 and p2x2/3 antagonistsROCHE PALO ALTO LLC·Filed 2015·Application pending·0 cites
- 1547US10315997B2Cyclopropyl unsaturated quinoline compound used as leukotriene receptor antagonist and applications thereofGUANGDONG MOLTECH PHARMA CO LTD·Filed 2015·Granted Jun 11, 2019·0 cites·3 claims
- 1645US2014206702A1Imidazopyridine compounds, compositions and methods of useGENENTECH INC·Filed 2014·Application pending·0 cites
- 1745US2004220235A1Method of inhibiting amyloid protein aggregation and imaging amyloid depositsFiled 2004·Application pending·0 cites
- 1838US2013096104A1Imidazopyridine compounds, compositions and methods of useLAI YINGJIE·Filed 2011·Application pending·0 cites
- 1938US2002143012A1Phenoxazine analogs useful as amyloid aggregation inhibitors and treatment of alzheimer's disease and disorders related to amyloidosisFiled 2001·Application pending·0 cites
- 2036US10385000B2Method for synthesizing 2-fluorocyclopropane carboxylic acidCHEN STONE GUANGZHOU CO LTD·Filed 2017·Granted Aug 20, 2019·0 cites·10 claims
- 2132US10358417B2Method for preparing efficiently synthetic sitafloxacin intermediate (7S)-5-azaspiro[2.4]heptane-7-yl tert-butyl carbamateCHEN STONE GUANGZHOU CO LTD·Filed 2017·Granted Jul 23, 2019·0 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →